Skip to main content
    P

    Protagenic Therapeutics (PTIX)

    Official site

    BIOTECHNOLOGY

    $0.80
    -0.01 (-0.74%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    100%(3/3)
    Avg Surprise
    +12.71%
    Streak
    8 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 26
    		$-0.47N/AN/ABeat-232.2%
    Jun 25
    Reported Aug 29
    		$-1.37N/AN/ABeat-277.9%
    Mar 25
    Reported May 13
    		$-2.75N/AN/ABeat-618.8%
    Dec 24
    Reported Mar 31
    		$-0.24$0.00N/ABeat+25.9%
    Sep 24
    Reported Nov 12
    		$-0.14$0.00N/ABeat+49.3%
    Jun 24
    Reported Aug 14
    		$-0.36$0.00N/ABeat-117.4%
    Mar 24
    Reported May 15
    		$-0.38$0.00N/ABeat-175.1%
    Sep 23
    Reported Nov 14
    		$-0.32$0.00N/ABeat-502.8%
    Jun 23
    Reported Aug 14
    		$-0.28N/AN/ABeat-598.3%
    Mar 23
    Reported May 15
    		$-0.17$0.00N/AMiss+94.0%
    Dec 22
    Reported Mar 31
    		$-0.14$0.00N/AMiss+95.0%
    Sep 22
    Reported Nov 14
    		$-0.05$0.00N/AMiss+98.1%
    Jun 22
    Reported Aug 11
    		$-0.04$0.00N/ABeat+63.6%
    Mar 22
    Reported Apr 7
    		$-2.79$-2.80+0.36%Beat-2436.4%
    Dec 21
    Reported Mar 2
    		$-2.79$-2.80+0.28%Beat-5484.4%
    Sep 21
    Reported Nov 15
    		$-2.80$-4.48+37.50%Beat-2700.0%
    Jun 21
    Reported Aug 16
    		$-0.11N/AN/ABeat-10.0%
    Mar 21
    Reported May 17
    		$-0.11N/AN/ABeat-120.0%
    Dec 20
    Reported Mar 25
    		$-0.05N/AN/ABeat-2.9%
    Sep 20
    Reported Nov 16
    		$-0.10N/AN/ABeat-36.8%
    Jun 20
    Reported Aug 14
    		$-0.10N/AN/ABeat-733.3%
    Mar 20
    Reported Jun 18
    		$-0.05N/AN/ABeat-84.5%
    Dec 19
    Reported Mar 31
    		$-0.05N/AN/ABeat+16.8%
    Sep 19
    Reported Nov 14
    		$-0.07N/AN/ABeat+5.1%
    Jun 19
    Reported Sep 30
    		$-0.01N/AN/ABeat+75.3%
    Mar 19
    Reported Jun 30
    		$-0.03N/AN/ABeat+58.6%
    Dec 18
    Reported Feb 22
    		$-0.06N/AN/ABeat-0.2%
    Sep 18
    Reported Nov 9
    		$-0.08N/AN/ABeat-13.6%
    Jun 18
    Reported Aug 10
    		$-0.05N/AN/ABeat-9.5%
    Mar 18
    Reported May 15
    		$-0.07N/AN/ABeat-48.6%
    Dec 17
    Reported Feb 23
    		$-0.06N/AN/ABeat+9.0%
    Sep 17
    Reported Nov 13
    		$-0.07N/AN/ABeat-
    Jun 17
    Reported Aug 8
    		$-0.04N/AN/ABeat-
    Mar 17
    Reported May 15
    		$-0.04N/AN/ABeat-
    Dec 16
    Reported Mar 31
    		$-0.06N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage1.52x
    Current Ratio0.66xQuick Ratio0.66x
    Trading Statistics
    BetaN/AAvg Volume3.86K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.78
    SMA 20$0.80
    SMA 50$0.75
    SMA 200$0.57
    EMA 10$0.79
    EMA 20$0.80
    EMA 50$0.73
    EMA 200$0.94

    MACD

    Line: 0.00Signal: 0.01Hist: -0.01

    ADX

    ADX: 23.5+DI: 35.2-DI: 23.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down24.0
    PSAR$0.83

    Bollinger Bands

    Upper Band$0.90
    Lower Band$0.71
    %B Position2372%(Upper)
    Band Width0.48

    RSI (14-Day)

    Neutral
    51.1

    Momentum Oscillators

    Stoch %K58.9
    Stoch %D37.6
    Williams %R-38.7
    ROC (10d)-1.2%
    Momentum-0.01
    CCI (20d)-6.5
    MFI (14d)33.6

    Volatility Measures

    ATR (14d)$0.04(5.6%)
    StdDev (20d)0.05
    Hist Vol112.3%(High)

    Volume Flow

    VWAP$0.80
    OBV245.3M
    AD Line858.3M
    CMF (20d)0.041

    Volume Metrics

    Avg Vol (20d)3.5K
    Vol Ratio0.2x(Low)
    VWMA (20d)$0.85

    Pivot Points

    R3$0.81
    R2$0.81
    R1$0.81
    Pivot Point$0.81
    S1$0.81
    S2$0.81
    S3$0.81

    Advanced Oscillators

    TSI0.41
    Ultimate Osc60.5
    KST95.07

    Financial Data

    QuarterSep 2026Jun 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$0$0$0$0$0$0$0$0N/A$0
    Gross Profit$0$0$0$0$0$0$0$0$0$0N/A$0
    Operating Expenses$925,103$961,247$925,103$1.11M$1.21M$1.45M$401,401$355,374$1.67M$1.74M$1.21M$1.43M
    R&D$153,786$109,925$153,786$273,229$394,112$880,372$134,580$16,964$1.21M$1.46M$1.01M$1.12M
    SG&A$400,644$382,522$400,644$233,158$206,849$567,736$201,216$191,169$453,298$277,613$200,799$307,682
    Operating Income$-925,103$-961,247$-925,103$-1,113,864$-1,208,374$-1,448,108$-401,401$-355,374$-1,667,347$-1,738,359$-1,212,226$-1,431,712
    Interest Income$0$0$0$0$0$8,103$9,026$0$9,291$13,867$53,657$69,218
    Interest Expense$-23,831$-10,763$-23,831$-34,337$1.37M$0$448,886$238,727$0$0$12,852$31,957
    Income Before Tax$2.21M$-963,616$2.21M$-869,496$-5,057,523$-1,440,005$-850,287$-584,911$-1,606,522$-1,724,294$-1,676,184$-1,396,626
    Income Tax Expense$0$0$0$0$0$0$0$-2,524$0$0$0$0
    Net Income$2.21M$-963,616$2.21M$-869,496$-5,057,523$-1,440,005$-850,287$-582,387$-1,606,522$-1,724,294$-1,676,184$-1,396,626
    EBITDA$2.20M$-966,067$2.20M$-903,833$-3,426,834$-1,435,536$-221,359$-333,612$-1,603,242$-1,725,589$-1,175,371$-1,407,014
    EBIT$2.19M$-974,379$2.19M$-903,833$-3,682,758$-1,448,108$-401,401$-346,184$-1,615,813$-1,738,161$-1,212,226$-1,433,887
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PTIX

    News

    No news available

    Company news will appear here when available

    PTIX Valuation and Fair Value

    P/B
    0.8x
    See GNG's fair value

    PTIX Competitors

    CompanyTicker
    Curis IncCRIS
    Iterum Therapeutics PLCITRM
    Oragenics IncOGEN
    Mobile-health Network Solutions Class A Ordinary SharesMNDR
    Genprex IncGNPX
    VSee Health, Inc.VSEE
    Nexgel IncNXGL
    Scinai Immunotherapeutics LtdSCNI

    Sector: Healthcare

    PTIX Bull Case vs Bear Case

    Bear case

    • PTIX beat EPS estimates in 0.0% of its last 8 reported quarters.

    PTIX Earnings: Beat Rate and Next Report

    Beat rate
    0 of 8 quarters (0.0%)

    Frequently Asked Questions About PTIX

    Does PTIX pay dividends?

    Protagenic Therapeutics (PTIX) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In